70 related articles for article (PubMed ID: 16774755)
41. Association of low plasma antioxidant levels with all-cause mortality and coronary events in healthy middle-aged men from France and Northern Ireland in the PRIME study.
McKay GJ; Lyner N; Linden GJ; Kee F; Moitry M; Biasch K; Amouyel P; Dallongeville J; Bongard V; Ferrières J; Gey KF; Patterson CC; Woodside JV
Eur J Nutr; 2021 Aug; 60(5):2631-2641. PubMed ID: 33355688
[TBL] [Abstract][Full Text] [Related]
42. Awareness, treatment and control of hyperlipidaemia in middle-aged men in France and northern ireland in 1991-1993: the PRIME study. Prospective epidemiological study of myocardial infarction.
Marques-Vidal P; Arveiler D; Evans A; Amouyel P; Ferrieres J; Luc G; Ducimetière P;
Acta Cardiol; 2002 Apr; 57(2):117-23. PubMed ID: 12003258
[TBL] [Abstract][Full Text] [Related]
43. Psychosocial risk factors for heart disease in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Sykes D; Arveiler D; Salters CP; Ferrieres J; McCrum E; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Ducimetiere P; Evans AE
Int J Epidemiol; 2002 Dec; 31(6):1227-34. PubMed ID: 12540727
[TBL] [Abstract][Full Text] [Related]
44. Protein Z plasma levels are not associated with the risk of coronary heart disease: the PRIME Study.
Morange PE; Juhan-Vague I;
J Thromb Haemost; 2004 Nov; 2(11):2050-1. PubMed ID: 15550045
[No Abstract] [Full Text] [Related]
45. Risk prediction-Homocysteine in Coronary Heart Disease.
Harish RB; Govindaraju V; Manjunath CN
Indian J Clin Biochem; 2007 Mar; 22(1):18-21. PubMed ID: 23105646
[TBL] [Abstract][Full Text] [Related]
46. Expanding and understanding risk factors for coronary heart disease.
DeRose DJ; Mullen K; Muscat J
JAMA; 1997 Aug; 278(8):636. PubMed ID: 9272894
[No Abstract] [Full Text] [Related]
47. MONICA/ECTIM meeting report: heart attacks in France and Northern Ireland. 23-24 April 1993. Abstracts.
Ulster Med J; 1993 Oct; 62(2):184-206. PubMed ID: 8303805
[No Abstract] [Full Text] [Related]
48. What determines drop out in prospective studies of coronary heart disease risk factors between youth and young adulthood: the Young Hearts Study.
van Lenthe FJ; Boreham CA; Twisk JW; Savage MJ; Murray L; Smith GD
J Epidemiol Community Health; 2001 Sep; 55(9):681-2. PubMed ID: 11511649
[No Abstract] [Full Text] [Related]
49. Ask the Doctor: I keep reading that homocysteine is an important new risk factor for heart disease, but my doctor says this test is not yet "ready for prime time." What's the holdup?
Harv Heart Lett; 2002 Jan; 12(5):7. PubMed ID: 11823153
[No Abstract] [Full Text] [Related]
50. [Homocysteine symposium. Nice, France, 15 October 1999. Abstracts].
Ann Biol Clin (Paris); 2000; 58(2):212-26. PubMed ID: 10760710
[No Abstract] [Full Text] [Related]
51. Effect of cerebral small vessel disease on cognitive impairment in Parkinson's disease.
Shen Y; Dong Z; Zhong J; Pan P; Xu G; Zhang Z; Zhang X; Shi H
Acta Neurol Belg; 2023 Apr; 123(2):487-495. PubMed ID: 36097211
[TBL] [Abstract][Full Text] [Related]
52. Plasma homocysteine is associated with aortic arterial stiffness but not wave reflection in Chinese hypertensive subjects.
Xiao W; Bai Y; Ye P; Luo L; Liu D; Wu H; Bai J
PLoS One; 2014; 9(1):e85938. PubMed ID: 24475061
[TBL] [Abstract][Full Text] [Related]
53. Association of serum total bilirubin levels with the severity, extent and subtypes of coronary atherosclerotic plaques detected by coronary CT angiography.
Canpolat U; Aytemir K; Yorgun H; Hazırolan T; Kaya EB; Şahiner L; Sunman H; Tokgözoğlu L; Kabakcı G; Oto A
Int J Cardiovasc Imaging; 2013 Aug; 29(6):1371-9. PubMed ID: 23546648
[TBL] [Abstract][Full Text] [Related]
54. Contribution of dietary intakes of antioxidants to homocysteine-induced low density lipoprotein (LDL) oxidation in atherosclerotic patients.
Seo H; Oh H; Park H; Park M; Jang Y; Lee M
Yonsei Med J; 2010 Jul; 51(4):526-33. PubMed ID: 20499417
[TBL] [Abstract][Full Text] [Related]
55. Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study.
Golledge J; Norman PE
Hum Genet; 2008 Feb; 123(1):35-40. PubMed ID: 17999084
[TBL] [Abstract][Full Text] [Related]
56. Homocysteine and coronary heart disease risk in the PRIME study.
Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
Atherosclerosis; 2007 Mar; 191(1):90-7. PubMed ID: 16774755
[TBL] [Abstract][Full Text] [Related]
57. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study.
Yarnell J; Yu S; McCrum E; Arveiler D; Hass B; Dallongeville J; Montaye M; Amouyel P; Ferrières J; Ruidavets JB; Evans A; Bingham A; Ducimetière P;
Int J Epidemiol; 2005 Apr; 34(2):268-75. PubMed ID: 15319403
[TBL] [Abstract][Full Text] [Related]
58. Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study.
Troughton JA; Woodside JV; Yarnell JW; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Luc G;
Atherosclerosis; 2008 Apr; 197(2):556-63. PubMed ID: 17900591
[TBL] [Abstract][Full Text] [Related]
59. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):79-84. PubMed ID: 17301631
[TBL] [Abstract][Full Text] [Related]
60. Fasting insulin concentrations and coronary heart disease incidence in France and Northern Ireland: the PRIME Study.
Bataille V; Perret B; Troughton J; Amouyel P; Arveiler D; Woodside J; Dallongeville J; Haas B; Bingham A; Ducimetière P; Ferrières J
Int J Cardiol; 2006 Apr; 108(2):189-96. PubMed ID: 15925416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
